Home  >  Press Release  >  News  

Aeon Astron Europe BV hereby announces that it has received US FDA 510K clearance letter for its collagen matrix used for the management of wounds.
2009/8/3
 
[3 August 2009 Leiden, The Netherlands]
Aeon Astron Europe BV hereby announces that it has received US FDA 510K clearance letter for its collagen matrix used for the management of wounds.

The issued number is K080868. For further information, please visit
 
Related Link :  http://www.accessdata.fda.gov/cdrh_docs/pdf8/K080868.pdf
 


Copyright © 2008 Aeon Astron Corporation All rights reserved.

website design / webhosting by fansio